Nuclera launches GPCR-focused nanodisc panel to streamline membrane protein production
Nuclera, the biotechnology company enabling rapid access to high-quality proteins, today announced the launch of its nanodisc panel to support screening and scale-up of G-Protein Coupled Receptors (GPCRs). Building on the eProtein Discovery™ membrane...
Wave Plummets 50% on Obesity Data
Disappointed investors punished Wave Life Sciences (NASDAQ: WVE), causing its shares to lose roughly half their value on Thursday after the RNA-based drug developer reported mixed early-stage clinical data for its obesity candidate WVE-007,...
Gut-Immune Link Identified in Multiple Sclerosis-Related Neuroinflammation
Multiple sclerosis (MS) is a debilitating neurological disorder caused by malfunctioning immune responses that target the brain and spinal cord of the central nervous system (CNS). New research led by Shohei Suzuki, MD, PhD,...
Stem Cells at the Frontier: Breakthroughs, Barriers, and What’s Next
Register Now Panelists:
Robert Signer, PhD Associate Professor, MedicineUniversity of California San Diego View Bio
Panelist ...
Egg-Based Biologics Drive Neion Bio Pharma Deal
Neion Bio has emerged from stealth mode and signed its first co-development and supply agreement with an unnamed major global pharmaceutical company. Neion’s Raptor platform products recombinant biologics in eggs, enabling scalable and efficient...
From Variability to Reliability: A New IgG4 Reference Standard for Consistent Characterization
Register Now Panelists:
Derrick Zhang Senior Scientist IIUS Pharmacopeia (USP) View Bio
Panelist ...
CDC tracks SARS-CoV-2 BA.3.2 global rise and finds early signals in U.S. wastewater
A new CDC report shows how traveler screening and wastewater monitoring detected the emerging BA.3.2 variant early, offering a clearer view of its spread, immune-evasion potential, and public health significance.
Key takeaways
BA.3.2 spread internationally after...
Judge’s Halt on RFK Jr.’s Vaccine Changes Remains in Effect, At Least for Now
Brian Murphy, a U.S. District Judge in Massachusetts, recently temporarily blocked key parts of RFK Jr.’s plan to change the U.S. childhood vaccine schedule. Judge Murphy sided with medical groups who maintained that changes...
Insilico and ASKA partner to advance AI-driven gynecological drug discovery
Mar 24 2026
Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced a strategic research collaboration with ASKA Pharmaceutical Co., Ltd. ("ASKA"), a specialized pharmaceutical company...
Modified Lipid Nanoparticles Boost mRNA Vaccine Delivery to Lymph Nodes
Lipid nanoparticles have become the workhorse of mRNA vaccines, ferrying genetic cargo into cells so the immune system can learn to recognize a threat. But most LNPs don’t travel where vaccine developers would ideally...
